Keckley Report March 15, 2021
Paul Keckley

In 2021, record levels of private investment will flow into the U.S. healthcare system accelerating merger and acquisition activity and fundamentally altering competition in the industry as organizations look beyond the pandemic.

Financial sponsors i.e. private equity, hedge funds, large-cap multi-nationals operating in the U.S., ended 2020 with $2.9 trillion cash on hand to invest. Of more than 300 ‘blank check’ aka Special Purpose Acquisition Companies are looking for acquisitions–53 focused exclusively on healthcare deals. Last year, a record 7 unicorns ($1 billion in revenues and privately owned) went public with names like Oscar, 23 and Me, One Medical, GoodRx and others now publicly traded. And notwithstanding growth in recent short-seller activity as some think SPACs might pay too...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Healthcare System, Insurance, Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Technology, Trends
Private equity & ASCs: 5 notes
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Zephyr AI Raises $111 Million in Series A Financing
Private equity pushes wave of healthcare bankruptcies

Share This Article